A Study to Evaluate the Efficacy and Safety of JYP0061 in Patients With Acute Neuromyelitis Spectrum Disease (NMOSD)
Clinical trial NCT06697535 · RECRUITING
Trial details
- NCT number
- NCT06697535
- Sponsor
- Guangzhou JOYO Pharma Co., Ltd
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-24
- Primary completion
- 2026-02-28
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.